Anil Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 0.50 M
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 138.00 Cr
- Satisfied Charges ₹ 257.00 Cr
- Revenue Growth %
- Profit Growth 1453.69%
- Ebitda 23594.03%
- Net Worth 957.37%
- Total Assets 379.28%
About Anil Life Sciences
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230GJ2010PLC059622
-
Company No.
059622
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
17 Feb 2010
-
Date of AGM
30 Sep 2015
-
Date of Balance Sheet
31 Mar 2015
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Anil Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amol Sheth
|
Additional Director | 17-Feb-2010 | Current |
|
Vishad Jagasheth
|
Additional Director | 15-Jun-2016 | Current |
|
Ashish Shah
|
Additional Director | 13-Aug-2016 | Current |
Financial Performance of Anil Life Sciences.
Anil Life Sciences Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1453.69% increase in profit. The company's net worth Soared by an impressive increase of 957.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anil Life Sciences?
In 2015, Anil Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Anil Bioplus LimitedAmol Sheth, Vishad Jagasheth and 1 more are mutual person
-
Alana Trading Limited Liability Partners HipAmol Sheth is a mutual person
-
Naimesh Trading Private Limited
Amol Sheth is a mutual person
-
Abner Enterprise Private Limited
Amol Sheth is a mutual person
-
Adella Enterprise Private Limited
Amol Sheth is a mutual person
-
Ascent Lifestyle Private Limited
Ashish Shah is a mutual person
Charges (Loans)
₹138.00 Cr
₹257.00 Cr
Charges Breakdown by Lending Institutions
- Others : 138.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jul 2016 | Others | ₹113.00 Cr | Open |
| 17 Feb 2016 | Others | ₹25.00 Cr | Open |
| 16 Oct 2014 | Axis Bank Limited | ₹128.50 Cr | Satisfied |
| 15 Jul 2014 | Axis Bank Limited | ₹128.50 Cr | Satisfied |
How Many Employees Work at Anil Life Sciences?
Unlock and access historical data on people associated with Anil Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anil Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anil Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
